Looking to expand your partner network with leading companies like EMBL? Consider joining Inpart's global network for free.
News and Trends 25 May 2017
Resilient Tumor Cells Drive Breast Cancer Relapse in Mice
Tumor cells that survive chemotherapy and drive breast cancer relapse may provide drug targets for potential treatments to reduce the recurrence. In mice, some breast tumor cells can survive chemotherapy and drive the recurrence of tumor, found a team of researchers from the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany and in Monterotondo, Italy; […]
